142 related articles for article (PubMed ID: 31977455)
21. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
[TBL] [Abstract][Full Text] [Related]
22. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
23. Metastatic Renal Cell Carcinoma in the Thyroid Gland and Pancreas Showing Uptake on 68Ga DOTATATE PET/CT Scan.
Kanthan GL; Schembri GP; Samra J; Roach P; Hsiao E
Clin Nucl Med; 2016 Jul; 41(7):583-4. PubMed ID: 27055137
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous Head and Neck Paraganglioma With Distinct Features on 123 I-MIBG and 68 Ga-DOTATATE Images.
Lu Y
Clin Nucl Med; 2022 Sep; 47(9):813-814. PubMed ID: 35353764
[TBL] [Abstract][Full Text] [Related]
25. Head-to-Head Comparison of
Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
[No Abstract] [Full Text] [Related]
26. Diagnosis, Treatment Response, and Prognosis: The Role of
Piccardo A; Morana G; Puntoni M; Campora S; Sorrentino S; Zucchetta P; Ugolini M; Conte M; Cistaro A; Ferrarazzo G; Pescetto M; Lattuada M; Bottoni G; Garaventa A; Giovanella L; Lopci E
J Nucl Med; 2020 Mar; 61(3):367-374. PubMed ID: 31541036
[TBL] [Abstract][Full Text] [Related]
27. Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET/CT.
Xiao J; Zhu Z; Zhong D; Ma W; Wang R
Clin Nucl Med; 2015 Feb; 40(2):e129-31. PubMed ID: 24873798
[TBL] [Abstract][Full Text] [Related]
28. Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia.
Ding J; Hu G; Wang L; Li F; Huo L
Clin Nucl Med; 2018 Dec; 43(12):880-886. PubMed ID: 30273206
[TBL] [Abstract][Full Text] [Related]
29. Should
Babazadeh NT; Schlund DJ; Cornelius T; Singh JS; Tierney JF; Chen M; Keutgen XM
World J Surg; 2020 Feb; 44(2):604-611. PubMed ID: 31576440
[TBL] [Abstract][Full Text] [Related]
30. A rare adult renal neuroblastoma better imaged by
Jain TK; Singh SK; Sood A; Ashwathanarayama AG; Basher RK; Shukla J; Mittal BR
Hell J Nucl Med; 2017; 20(1):100-101. PubMed ID: 28315919
[TBL] [Abstract][Full Text] [Related]
31. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
Tran K; Khan S; Taghizadehasl M; Palazzo F; Frilling A; Todd JF; Al-Nahhas A
Hell J Nucl Med; 2015; 18(1):19-24. PubMed ID: 25679074
[TBL] [Abstract][Full Text] [Related]
32. ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.
Subramaniam RM; Bradshaw ML; Lewis K; Pinho D; Shah C; Walker RC
Clin Nucl Med; 2018 Dec; 43(12):899-908. PubMed ID: 30394933
[TBL] [Abstract][Full Text] [Related]
33. Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.
Tan TH; Wong TH; Hassan SZ; Lee BN
Clin Nucl Med; 2015 Nov; 40(11):867-8. PubMed ID: 26252329
[TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
[TBL] [Abstract][Full Text] [Related]
35. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
36. Recurrent/Residual Intracranial Phosphaturic Mesenchymal Tumor Revealed on 68Ga-DOTATATE PET/CT.
Ding J; Wang L; Zhang S; Li F; Huo L
Clin Nucl Med; 2018 Sep; 43(9):674-675. PubMed ID: 30015664
[TBL] [Abstract][Full Text] [Related]
37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
39. Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
Zhang W; Zhuang H; Servaes S
Clin Nucl Med; 2016 Aug; 41(8):632-3. PubMed ID: 26825196
[TBL] [Abstract][Full Text] [Related]
40. Metastatic Neuroblastoma in Adult Patient, Presenting as a Super Scan on 68Ga-DOTANOC PET/CT Imaging.
Malik D; Jois A; Singh H; Bora GS; Basher RK; Mittal BR
Clin Nucl Med; 2017 Sep; 42(9):697-699. PubMed ID: 28682847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
